News

This week's exercise is a perfect addition for someone on a GLP-1 prescription, because it addresses another element of ...
In a striking new study, the anti-obesity drug tirzepatide, known as Mounjaro and Zepbound, not only triggered significant ...
A new study finds four factors that may make it more likely for some people to experience successful weight loss from using ...
CVS Caremark will stop covering Eli Lilly’s Zepbound. Wegovy, the GLP-1 medication to treat obesity from Lilly competitor ...
The country’s Medicines and Healthcare products Regulatory Agency’s Yellow Card scheme, the UK’s official system for ...
Ongoing research is needed to fully understand their risks, especially for long-term and higher-dose users. However, many ...
Some weight loss drugs may cause hair loss. While it’s typically a temporary side effect, it can affect your confidence.
Study finds the GLP-1 drug liraglutide reduced migraine days by almost 50% in patients with obesity, with quality of life ...
The decline of real-life slimming clubs is down to a variety of factors, says Kate. ‘Diets come in fads — at the moment, ...
Weight loss drugs pose a danger to boys and men. A study of the drugs Ozempic and Wegovy found that males who used them ...